换一批Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.
第一作者：
Brad H,Nelson
第一单位：
Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada.;Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.;Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
作者：
Brad H,Nelson [1]
;
Phineas,Hamilton [2]
;
Minh Tung,Phung [3]
;
Katy,Milne [2]
;
Bronwyn,Harris [2]
;
Shelby,Thornton [2]
;
Donald,Stevens [2]
;
Shreena,Kalaria [4]
;
Karanvir,Singh [2]
;
Céline M,Laumont [5]
;
Elena,Moss [2]
;
Aliya,Alimujiang [6]
;
Nicola S,Meagher [7]
;
Adelyn,Bolithon [8]
;
Sian,Fereday [9]
;
Catherine J,Kennedy [10]
;
Joy,Hendley [11]
;
Dinuka,Ariyaratne [11]
;
Kathryn,Alsop [9]
;
Nadia,Traficante [12]
;
Ellen L,Goode [13]
;
Anthony,Karnezis [14]
;
Hui,Shen [15]
;
Jean,Richardson [16]
;
Cindy,McKinnonDeurloo [17]
;
Anne,Chase [17]
;
Bronwyn,Grout [17]
;
Jennifer Anne,Doherty [18]
;
Holly R,Harris [19]
;
Kara L,Cushing-Haugen [20]
;
Michael,Anglesio [21]
;
Karolin,Heinze [21]
;
David,Huntsman [22]
;
Aline,Talhouk [21]
;
Gillian E,Hanley [21]
;
Jennifer,Alsop [23]
;
Mercedes,Jimenez-Linan [24]
;
Paul Dp,Pharoah [25]
;
Jessica,Boros [10]
;
Alison H,Brand [26]
;
Paul R,Harnett [27]
;
Raghwa,Sharma [28]
;
Jonathan L,Hecht [29]
;
Naoko,Sasamoto [30]
;
Kathryn L,Terry [31]
;
Beth,Karlan [32]
;
Jenny,Lester [32]
;
Michael E,Carney [33]
;
Marc T,Goodman [34]
;
Brenda Y,Hernandez [35]
;
Lynne R,Wilkens [35]
;
Sabine,Behrens [36]
;
Renée,Turzanski Fortner [37]
;
Peter A,Fasching [38]
;
Christiani,Bisinotto [39]
;
Francisco José,Candido Dos Reis [39]
;
Prafull,Ghatage [40]
;
Martin,Köbel [41]
;
Esther,Elishaev [42]
;
Francesmary,Modugno [43]
;
Linda,Cook [44]
;
Nhu,Le [45]
;
Aleksandra,Gentry-Maharaj [46]
;
Usha,Menon [47]
;
María J,García [48]
;
Cristina,Rodriguez-Antona [49]
;
Kyo,Farrington [41]
;
Linda E,Kelemen [50]
;
Stefan,Kommoss [51]
;
Annette,Staebler [52]
;
Dale W,Garsed [9]
;
James D,Brenton [53]
;
Anna M,Piskorz [53]
;
David Dl,Bowtell [9]
;
Anna,DeFazio [54]
;
Susan J,Ramus [8]
;
Malcolm C,Pike [55]
;
Celeste Leigh,Pearce [6]
作者单位：
Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada.;Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.;Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
[1]
Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada.
[2]
School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.;Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
[3]
Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada.;Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
[4]
Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada.;Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
[5]
School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
[6]
School of Clinical Medicine, University of New South Wales (NSW) Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.;The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
[7]
School of Clinical Medicine, University of New South Wales (NSW) Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.;Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.
[8]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
[9]
Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
[10]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[11]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
[12]
Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
[13]
Department of Pathology, University of California Davis School of Medicine, Sacramento, California, USA.
[14]
Van Andel Institute, Grand Rapids, Michigan, USA.
[15]
Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.;Patient advocate.
[16]
Patient advocate.
[17]
Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA.
[18]
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.;Department of Epidemiology, University of Washington, Seattle, Washington, USA.
[19]
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
[20]
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.;British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, British Columbia, Canada.
[21]
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.;Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
[22]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
[23]
Department of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom.
[24]
Department of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, California, USA.
[25]
Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
[26]
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.;Crown Princess Mary Cancer Centre and.
[27]
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.;Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Westmead Hospital, Sydney, New South Wales, Australia.;Western Sydney University, Sydney, New South Wales, Australia.
[28]
Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
[29]
Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
[30]
Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
[31]
David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California, USA.
[32]
Department of Obstetrics and Gynecology, John A. Burns School of Medicine University of Hawaii, Honolulu, Hawaii, USA.
[33]
Cancer Prevention and Control Program, Cedars-Sinai Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[34]
University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
[35]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[36]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Department of Research, Cancer Registry of Norway, Oslo, Norway.
[37]
Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
[38]
Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
[39]
Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
[40]
Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada.
[41]
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
[42]
Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.;Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.;Women's Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
[43]
Epidemiology, School of Public Health, University of Colorado, Aurora, Colorado, USA.;Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
[44]
Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada.
[45]
MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology and.;Department of Women's Cancer, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, United Kingdom.
[46]
MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology and.
[47]
Cancer Biology Department, Sols-Morreale Biomedical Research Institute (IIBM), CSIC UAM, Madrid, Spain.
[48]
Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.;Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
[49]
Division of Acute Disease Epidemiology, South Carolina Department of Health and Environmental Control, Columbia, South Carolina, USA.
[50]
Department of Women's Health and.
[51]
Institute of Pathology and Neuropathology, Tuebingen University Hospital, Tuebingen, Germany.
[52]
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
[53]
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.;Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
[54]
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[55]
医学主题词
成年人(Adult);老年人(Aged);女(雌)性(Female);人类(Humans);中年人(Middle Aged);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);肿瘤蛋白质类(Neoplasm Proteins);卵巢肿瘤(Ovarian Neoplasms);肿瘤微环境(Tumor Microenvironment)
DOI
10.1172/JCI179501
PMID
39470729
发布时间
2026-03-26
- 浏览0
The Journal of clinical investigation
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
